Liraglutide improves cardiac function in patients with type 2 diabetes and chronic heart failure.
Endocrine
; 57(3): 464-473, 2017 Sep.
Article
in En
| MEDLINE
| ID: mdl-27830456
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cardiotonic Agents
/
Diabetes Mellitus, Type 2
/
Diabetic Cardiomyopathies
/
Liraglutide
/
Heart
/
Heart Failure
/
Hypoglycemic Agents
Type of study:
Clinical_trials
Aspects:
Patient_preference
Language:
En
Journal:
Endocrine
Journal subject:
ENDOCRINOLOGIA
Year:
2017
Document type:
Article
Affiliation country:
Italy
Country of publication:
United States